arrow
P

Peter R. Galle

johannes-gutenberg university of mainz
H指数:128
被引数:10.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

EORTC-1607-GITCG/ABC-09: Open-label first-line, single-arm phase II study of CisGem combined with pembrolizumab in patients with advanced or metastatic biliary tract cancer

EORTC-1607-GITCG/ABC-09:西吉姆联合帕博利珠单抗治疗晚期或转移性胆道癌的开放标签、单臂II期首线研究

2026-08-010
PRE
Increased albuminuria is highly prevalent in the general population: prevalence of CKD in the Gutenberg Health Study

普通人群中尿白蛋白排泄率升高十分普遍:古滕贝格健康研究中的CKD患病率

2026-02-011
PRE
Neurofilament Light Chains in Serum Predict Post—Transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy

血清神经丝轻链可预测经颈静脉肝内门体分流术后肝性脑病

MedComm
IF10.7
2025-11-050
OAAI
A multicenter dose-defining/expansion phase 1b study of first-line regorafenib plus pembrolizumab in patients with advanced hepatocellular carcinoma

一项多中心剂量定义/扩展性 Ib 期研究,评估regorafenib联合pembrolizumab作为一线疗法在晚期肝细胞癌患者中的疗效。

2025-11-010
PRE
BCLC strategy for prognosis prediction and treatment recommendations: The 2025 update

用于预后预测和治疗建议的BCLC策略: 2025更新

2025-10-270
PRE
Incidence of major cardiovascular events in patients with metabolic dysfunction-associated steatotic liver disease in the general population

代谢功能障碍相关脂肪性肝病在普通人群中的主要心血管事件发生率

2025-09-260
OAAI
Lenvatinib versus sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: the LEVIATHAN Study

伦伐替尼对比索拉非尼作为阿替利珠单抗联合贝伐珠单抗后肝癌的二线治疗:LEVIATHAN 研究

2025-09-230
OAAI
Evaluating a population-based screening programme for early detection of liver fibrosis and cirrhosis in primary care in Germany: a cost assessment study

评估在德国初级保健中基于人群的筛查计划对肝纤维化和肝硬化的早期检测:一项成本评估研究

2025-09-180
OA
Health-related quality of life analysis of the LEAP-002 study of lenvatinib plus pembrolizumab versus lenvatinib as first-line treatment for advanced hepatocellular carcinoma

LEAP-002研究:lenvatinib联合pembrolizumab对比lenvatinib单药作为晚期肝细胞癌一线治疗的健康相关生活质量分析

2025-06-010
OA
Albumin infusion in hepatorenal syndrome-acute kidney injury: New evidence challenges recent consensus

Angeli, P.; Labenz, C.; Piano, S.; Juanola, A.; Krag, A.; Caraceni, P.; Trebicka, J.; Maiwall, R.; Singh, V.; Pose, E.; 等. 肝肾综合征-急性肾损伤中的白蛋白输注:新证据挑战近期共识. 肝脏病学杂志. 2025, 待发表. [谷歌学术] [CrossRef] [PubMed]

2025-04-170
PRE
Psychological resilience, cardiovascular disease, and mortality - Insights from the German Gutenberg Health Study
2025-04-010
OA